Sildenafil en hipertensión arterial pulmonar / Sildenafil therapy for pulmonary arterial hypertension
Rev. am. med. respir
; 8(4): 141-144, dic. 2008. tab, graf
Article
in Spanish
| LILACS
| ID: lil-534951
Responsible library:
AR1.1
RESUMEN
Los estudios que determinaron la aprobación de sildenafil para el tratamiento de la hipertensión arterial pulmonar han evaluado su efecto en el corto plazo (12 semanas). Pocos trabajos han mostrado los efectos de sildenafil en el mediano y largo plazo. El presente estudio describe la evolución de un grupo de pacientes tratados con sildenafil por un plazo medio de 39 semanas.
ABSTRACT
The use of sildenafil for pulmonary arterial hypertension treatment was aproved on the basis of short course time studies (12 weeks). Few studies have showed medium or long time benefits with this drug. The present paper presents the results of a medium course treatment with sildenafil in a group of patients.
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Phosphodiesterase Inhibitors
/
Hypertension, Pulmonary
Limits:
Adolescent
/
Adult
/
Female
/
Humans
Language:
Spanish
Journal:
Rev. am. med. respir
Journal subject:
Medicine
/
Pulmonary Disease (Specialty)
Year:
2008
Document type:
Article
Affiliation country:
Uruguay
Institution/Affiliation country:
Universidad de la República/UY